Plasmid

Plasmid designates a small, circular DNA molecule that exists independently of chromosomal DNA, primarily found in bacteria and used extensively as a molecular tool in biopharmaceutical manufacturing. These versatile genetic elements replicate autonomously within host cells, making them indispensable vectors for introducing therapeutic genes and producing recombinant proteins at industrial scale.

In modern biologics production, plasmids serve as the genetic blueprint for manufacturing therapeutic proteins including insulin, growth hormones, and monoclonal antibodies. Scientists engineer plasmids to contain specific gene sequences along with regulatory elements controlling expression levels. Regulatory authorities require comprehensive characterisation of plasmid constructs used in commercial production, including complete sequence verification and stability testing. Plasmid DNA vaccines represent an emerging therapeutic class demonstrating promise for rapid development and deployment. Leading biotechnology companies invest significantly in optimising plasmid production processes, recognising these molecular tools as foundational to biosimilar development, gene therapy manufacturing, and next-generation vaccine platforms. As plasmid technology matures and manufacturing processes improve, these fundamental genetic elements continue driving innovation across pharmaceutical research.